Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
First What you are saying is the stock price of biotechs in essence will always decrease? If that were the case then why on earth would anyone invest in an (early) stage biotech? There is absolutely no reason to invest in an biotech starting in its early development stage when its already settled the SP will decrease now is there. But NWBO is NOT in its early development stage now are they? Still, they are down 90% from the time LP took office.
Yes non revenue biotechs sell shares to finance its business. However, a well-run biotech, such as for example Anavex, trades shares for progress. So simply said biotech makes REAL ACTUAL progress SP rises, biotech dilutes SP decreases a small bit but stays above the SP it was before the reported progress, Biotech reports REAL ACTUAL progress SP rises etc. That's how well-run biotech works. Not NWBO. NWBO has not reported any progress but keeps diluting to keep financing a nonaffiliated other business thus SP tanks.
Advocating the never-ending decrease of NWBO SP as a good and natural phenomenon is absurd
since Linda Powers started as CEO the StockPice declined 90%.
Just let that sink in. mind-boggling.
All CEOs of all listed companies in every developed country especially the US are being settled on their performance by looking at the stock price performance, without exception. Ooh wait one exception according to the groupies not LP with a whopping -90%. Many CEOs of listed companies had to go over way less bad performance than that.
But of course its not Linda's fold, its the shorts, bears, wolf pack, AF, Novocure, the RA's etc fault. And of course its also the fault of longs like myself, PM, Grip etc pointing her performance out. Hey its even Flipper's fault when he says "continents are moving faster than NWBO". But not Lindas
NWBO experienced a first and last small short Sqeeuze in Oct 2020 when it run up to over 2.1$. There will never be another ever.
Im convinced the journal will appear before Liaus's Nov 20 talk, if not they will cancel SNO. Since canceling is kinda their thing Im not holding my breath until the JA has arrived TLD is on NWBO's website and Liau has spoken on Nov 20.
Im advising all NWBO longs todo the same (not holding your breath in anticipation)
here I disagree with you. The fact is we have already witnessed the topline data on May 10th. The TLD we have witnessed so far would provide a normal functional biotech approval to market DCVAX L with any of the 4 RAs hands down. This is a fact
Fact 2 is Dr. Ashkan has stated the JA has been submitted and is in peer review. Now that was the end Aug. So the JA should appear any day now including the official TLD.
The problem is NOT the data or DCVAX L or the JA because that has all been covered by excellent hard working MDs. The problem and concern is NWBO managing refusing to submit for approval so far and thus taking x2-x3 longer than a normal functioning biotech would with data as the DCVAXL trial provided.
Im out as well between $2 and $3
Hahaha trap the shorts. I forgot about that one.
Ooh good times lol
hahahah lol
No LP and LG have ZERO todo nor any credit to the invention of DCVAX L. LP or LG did not hire Liau or Ashkan its silly of you to suggest otherwise also ist spreading misinfo. LP and LG did not have anything to do with how patients were selected and treated in the medical trial. Its the MDs that deserve all the credit and despite the mismanagement of both LP and LG this medical trial is still a success.
LP and LG have bought themselves into NWBo and are here for the ride on the back of successful treatment. Thats it
I do believe Grip we will see news before Nov 20 I really do believe that.
Im however angered by the almost certain fact they have not filed a request for approval with any RA.
But I do believe there will be good news between now and Nov 19 95% sure. If it will lift the SP...?
Im in Anavex as well made a lot of money so far, not going to throw the numbers around tough.
Im an NWBO long and did not make any money its an unnecessarily losing streak so far. Will not sell if it takes 10,000 years.
NWBO is further in the trial process, yet Anavexs MC is bigger.
Long story short Anavex is an excellent biotech company with an exceptionally suitable CEO with all the right backgrounds. NWBO management is not.
Dont get in a 747 flown by your plastic surgeon.
LP is NOT focused on RA approvals. If she had focused on RA approvals then the approval would already have arrived 2 years and 2 weeks after data lock or at a minimum submitted a request for approval. You cant say someone is focussing on something if that time by a normal functioning someone or something is on average shorter than your focussing someone or something. Then its not focus, its Attention Deficit Hyperactivity Disorder.
If the company behaved like a normal company, announced official data, published, filed for approval - sued its detractors it would have attracted a broad group of investors into the marketplace to buy shares aka volume. If there is volume market markets can not toy around and longs, sick of the lack of transparency and never-ending silence would not sell, thus SP would rise. As it is, though, NWBO remains confusing, and there's a mist shrouding the path forward because the company chooses to remain silent. Thus no volume given the market markets ample options to toy around.
You are pointing towards one small aspect of the symptom, Me, SA article, Grip and others are describing the complete cause of the NWBO management sickness and why the patient is dwindling down.
Ha interesting idea
before I start waving my arms do you mean Linda P or Linda L? ;)
I agree. Or a BO tomorrow at $6-8 would be fine as well
yup. And mind you that in my view NWBO management is (in)directly responsible for the unnecessary suffering and passing of GBM patients so far with their F-you attitude towards urgency.
NWBO management is the market's true shorts, bears, and wolfpack this board has been talking about so many times over the years.
I was hoping that like any normal company, NWBO will unblind their trial, publish their data, and get on with the regulatory process.
I was hoping that as well. A normal function biotech. Only the dream of NWBO being like that.
https://seekingalpha.com/article/4547170-northwest-biotherapeutics-biopharmas-promising-delinquent?mailingid=29408460&messageid=2800&serial=29408460.3509&source=email_2800&utm_campaign=rta-stock-article&utm_medium=email&utm_source=seeking_alpha&utm_term=29408460.3509
Lol damn them indeed
Can you please describe what your definition of a "short" is (in the investment meaning of the word). Perhaps I fail to understand what it means.
It apparently according to you does NOT mean this:
"A short, or a short position, is created when a trader sells a security first with the intention of repurchasing it or covering it later at a lower price. A trader may decide to short a security when she believes that the price of that security is likely to decrease in the near future."
https://www.investopedia.com/terms/s/short.asp#:~:text=A%20short%2C%20or%20a%20short,decrease%20in%20the%20near%20future.
misinformation
your are 100% correct
Im sorry but you really can't take Annie Post seriously. I mean at all. The way she writes sounds like a 14-year-old giggle.
The SP is moving down for the buyers of the C's are selling their common at ever lower prices to finance their investment in C prefs. Its that simple. The irony is that the buyers of the Cs of two months ago are already looking at a loss now for doing what the C investors are doing today. I hope that anyone considering buying the Cs realizes that they just keep encouraging the never-ending kicking of the can.
I do agree they are moving in the direction of filing a request for MAA with the MHRA. I was pointing out as to put it in Flipper's description that continents move faster than NWBO AND that they are unnecessarily delaying all requests for approval which IMO is caused because of a lack of experience with NWBO management.
agreed :)
Yes thats the best way forward a BO. And you know what perhaps that's the reason they are not filing a request for marketing approval with any RA, it will be the new owner's job. It would also explain why they are, against Delaware law, still withholding the ASM. As a matter of fact at this point its the ONLY reasonable explanation. Any other reason is short of madness.
It would be best for everyone involved if NWBO would seize to exist asap and a BP takes over.
They haven't said anything bc they haven't achieved much or really anything.
Im incredibly angered and concerned over the lack of urgency to file for approval with any RA, heck at this point Im happy with the filing for a request for approval with the RA of Mozambique.
Any normal functioning biotech with the data they have in their hands would have already filed a request of some sort in any form with the FDA and EMA, period.
The reason why they have not is that they (LP and LG) lack the biotech experience to file a request for approval, but thank goodness they are lawyers.
lol sssssttt you are awakening the silent quiet period from its long term hybrid Northwest deep sleep.